Article

Medicare To Penalize 2,211 Hospitals For Excess Readmissions

More than 2,000 hospitals — including some nationally recognized ones — will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show.

Together, these hospitals will forfeit about $280 million in Medicare funds over the next year as the government begins a wide-ranging push to start paying health care providers based on the quality of care they provide.

Read the full story: http://tinyurl.com/c4weqf2

Source: Kaiser Health News

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Joseph Saseen, PharmD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Related Content
Hospital and ED use were similar at the individual and neighborhood levels, but the use of outpatient services differed. | Image credit: Spiroview Inc - stock.adobe.com
April 15th 2025

Individual, Neighborhood-Level Social Risk Indicators Provide Distinct Health Care Use Insights

Rose McNulty
While findings around hospital and emergency department use were similar at the individual and neighborhood levels, the use of outpatient services differed.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Patients with metabolic dysfunction-associated steatohepatitis carry an increased risks for cardiovascular disease and related events | image credit: reyanking999 - stock.adobe.com
April 15th 2025

Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH

Kyle Munz
A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
OS was the primary end point in the trial, and data from the planned interim analysis will be presented at an upcoming scientific meeting. | Image credit: Crystal light - stock.adobe.com
April 14th 2025

Tarlatamab Improves Overall Survival in Extensive-Stage SCLC

Jared Kaltwasser
The immunotherapy improved outcomes compared with standard chemotherapy in the global Phase 3 DeLLphi-304 trial.
Additional research, argued the researchers, should examine the impact of more accessibility to nutritious foods on binge eating. | Image Credit: dizain - stock.adobe.com
April 12th 2025

Identifying Binge Eating Triggers Among Adults With Food Insecurity

AJMC Contributor
Findings from the interviews offer insight into potential strategies for reducing binge eating among patients who experience food insecurity.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo